Home › NCT05073419

Arrhythmia Detection After MI

Arrhythmia Detection After Myocardial Infarction Trial

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adults, age 18 years or older
* AMI (STEMI and NSTEMI)
* Willing to give written informed consent
* Expected discharge from hospital within 7 days of AMI
* Willing to receive ICM insertion within 21 days of index AMI

Exclusion Criteria:

* Existing pacemaker, ICD, ICM, or any other implantable cardiac electronic device
* Pregnant
* Index AMI was more than 21 days
* Unwilling/cannot insert ICM within 21 days post AMI
* Planned ICD implant, planned CABG or any open-heart surgery (e.g. for severe valvular disease)

About the study

Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator. The same improvement was not demonstrated for the risk of sudden cardiac death. Monitoring patients after AMI using an implantable cardiac monitor (ICM) may document findings that can impact patient management and eventually improve their outcomes. We are therefore conducting the AID MI trial to examine the impact of ICM on patient management in the post AMI setting.

What is being tested

• Standard of Care (other)
• ICM Implantation (device)

Sponsor: Samir Saba · Participants: 200 · Started: Aug 9, 2022

Contact the study team

• Samir F Saba, MD · Phone: 412 647 2695
• Melissa Enlow · Phone: 412-647-1582

Official record on ClinicalTrials.gov — NCT05073419

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.